Gulsen Kama - Jun 3, 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/5/2024, 05:48 PM
Previous filing
Sep 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Award $0 +16K $0.00 16K Jun 3, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +75K $0.00 75K Jun 3, 2024 Common Stock 75K $0.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2 The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.
F3 The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.